Key facts
- This page summarizes Seokho Bryan Yoon's Form 4 filing for Terns Pharmaceuticals, Inc. (TERN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jun 2024, 18:06.
Seokho Bryan Yoon - 31 May 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)
- Reporting relationship
- COO and General Counsel
- Issuer ticker
- TERN
- Reported as of
- 31 May 2024
- Net transaction value
- +$21,272
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 18:06:20 UTC
- Prior SEC filing
- 25 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Seokho Bryan Yoon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Seokho Bryan Yoon filed Form 4 for Terns Pharmaceuticals, Inc. (TERN) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: +$21,272.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TERN
transaction
Common Stock
Purchase
- Transaction value
- $21,272
- Shares
- +4,791
- Change %
- +5.5%
- Price
- $4.44
- Shares after
- 91,940
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes the purchase of 4,791 shares under the Terns Employee Stock Purchase Plan on May 31, 2024.
SEC remarks
Voluntary reporting of ESPP purchase